Literature DB >> 11675189

Should mediastinal nodal dissection be routinely undertaken in patients with peripheral small-sized (2 cm or less) lung cancer? Retrospective analysis of 225 patients.

S Watanabe1, M Oda, T Go, Y Tsunezuka, Y Ohta, Y Watanabe, G Watanabe.   

Abstract

OBJECTIVE: We retrospectively reviewed nodal status of the patients with peripheral small-sized lung cancer grouped by cell type and tumor size to evaluate the necessity of systematic nodal dissection in this group of patients.
METHODS: From 1973 to 1998, 1713 patients underwent pulmonary resection for primary lung cancer in Kanazawa University. Among them, 225 patients (13.1%) with peripheral small-sized (2 cm or less) lung cancer underwent lobectomy and systematic nodal dissection were retrospectively reviewed. The maximum diameter of the tumor was measured on formalin-fixed surgical specimens.
RESULTS: The histological types were adenocarcinoma in 170 (75.6%), squamous cell carcinoma in 20 (8.9%), small cell carcinoma in 19 (8.4%) and others in 16 (7.1%). Among 170 adenocarcinoma patients, 38 (22.4%) showed hilar or mediastinal lymph node metastases. No mediastinal lymph node metastasis was encountered in all squamous cell carcinoma (n = 20), adenocarcinoma < or = 1 cm (n = 16), small cell carcinoma < or = 1 cm (n = 4), and adenocarcinoma of Noguchi's classification type A or B (n = 24).
CONCLUSIONS: Mediastinal nodal dissection would be unnecessary in the patients with peripheral small-sized lung cancer fulfilling these criteria: (1) squamous cell carcinoma < or = 2 cm; (2) adenocarcinoma < or = 1 cm; (3) localized bronchioloalveolar carcinoma < or = 2 cm without foci of active fibroblastic proliferation in histology (Noguchi's classification type A or B adenocarcinoma); (4) small cell carcinoma < or = 1 cm. Candidates fulfilling above criteria were 28.4% (64/225) of small-sized lung cancer and 10.9% of stage IA patients. The establishment of a universally accepted therapeutic strategy for small-sized lung cancer is indispensable in the clinical spread of various sort of limited resections.

Entities:  

Mesh:

Year:  2001        PMID: 11675189     DOI: 10.1016/s1010-7940(01)00954-x

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  16 in total

1.  Prognosis and status of lymph node involvement in patients with adenocarcinoma in situ and minimally invasive adenocarcinoma-a systematic literature review and pooled-data analysis.

Authors:  Long Jiang; Weiqiang Yin; Guilin Peng; Wei Wang; Jianrong Zhang; Yang Liu; Shengyi Zhong; Qihua He; Wenhua Liang; Jianxing He
Journal:  J Thorac Dis       Date:  2015-11       Impact factor: 2.895

2.  Lymph node metastasis, recurrence, and prognosis in small peripheral lung adenocarcinoma. Analysis based on replacement.

Authors:  Tohru Sakuragi; Yukinori Sakao; Hiroya Fujita; Masafumi Natsuaki; Tsuyoshi Itoh
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-10

3.  Small peripheral lung carcinomas with five-year post-surgical follow-up: assessment by semi-automated volumetric measurement of tumour size, CT value and growth rate on TSCT.

Authors:  Shusuke Sone; Takaomi Hanaoka; Hiroyuki Ogata; Fumiyoshi Takayama; Tomofumi Watanabe; Masayuki Haniuda; Kazuhiko Kaneko; Ryoichi Kondo; Kazuo Yoshida; Takayuki Honda
Journal:  Eur Radiol       Date:  2011-08-17       Impact factor: 5.315

4.  A clinicopathological study of resected non-small cell lung cancers 2 cm or less in diameter: a prognostic assessment.

Authors:  Chun-Lei Shi; Xue-Yan Zhang; Bao-Hui Han; Wei-Zhong He; Jie Shen; Tian-Qing Chu
Journal:  Med Oncol       Date:  2010-07-27       Impact factor: 3.064

5.  Results of surgical treatment for small (2 cm or under) adenocarcinomas of the lung.

Authors:  Yasushi Yamato; Teruaki Koike; Katsuo Yoshiya; Hirohiko Shinohara; Shinichi Toyabe
Journal:  Surg Today       Date:  2008-02-01       Impact factor: 2.549

Review 6.  Lymph node dissection for lung cancer: past, present, and future.

Authors:  Shun-ichi Watanabe
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-05-15

7.  Prognostic model based on circular RNA circPDK1 for resected lung squamous cell carcinoma.

Authors:  Xiao Sun; Maolong Wang; Rongjian Xu; Dongyang Zhang; Ao Liu; Yuanyong Wang; Tong Lu; Yanlu Xin; Yandong Zhao; Yunpeng Xuan; Tong Qiu; Hao Wang; Shicheng Li; Yang Wo; Dahai Liu; Jinpeng Zhao; Bo Fu; Yaliang Lan; Yudong Han; Wenjie Jiao
Journal:  Transl Lung Cancer Res       Date:  2019-12

8.  Comprehensive investigation of clinicopathologic features, oncogenic driver mutations and immunohistochemical markers in peripheral lung squamous cell carcinoma.

Authors:  Yang Zhang; Difan Zheng; Yuan Li; Yunjian Pan; Yihua Sun; Haiquan Chen
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

9.  Intrapulmonary lymph node (stations 13 and 14) metastasis in peripheral non-small cell lung cancer.

Authors:  Lei Bi; Hong Zhang; Mingjian Ge; Zhongzhu Lv; Yiping Deng; Tenghao Rong; Chaolun Liu
Journal:  Medicine (Baltimore)       Date:  2021-07-09       Impact factor: 1.817

10.  Nodal involvement pattern in resectable lung cancer according to tumor location.

Authors:  Somcharoen Saeteng; Apichat Tantraworasin; Juntima Euathrongchit; Nirush Lertprasertsuke; Yutthaphun Wannasopha
Journal:  Cancer Manag Res       Date:  2012-06-07       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.